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ABSTRACT  1 
 2 
A leading hypothesis proposes that increased human lifespan since 1850 has resulted from 3 
decreased exposure to childhood infections, which has reduced chronic inflammation and 4 
later-life mortality rates, particularly from cardiovascular disease, stroke and cancer. Early-5 
life cohort mortality rate often predicts later-life survival in humans, but such associations 6 
could arise from factors other than disease exposure. Additionally, the impact of early-life 7 
disease exposure on reproduction remains unknown, and thus previous work ignores a major 8 
component of fitness, through which selection acts upon life-history strategy. We collected 9 
data from seven 18th and 19th century Finnish populations experiencing naturally-varying 10 
mortality and fertility levels. We quantified early-life disease exposure as the de-trended 11 
child mortality rate from infectious diseases during an individual’s first five years, controlling 12 
for important social factors. We found no support for an association between early-life 13 
disease exposure and all-cause mortality risk after age 15 or 50. We also found no link 14 
between early-life disease exposure and probability of death specifically from cardiovascular 15 
disease, stroke or cancer. Independently of survival, there was no evidence to support 16 
associations between early-life disease exposure and any of several aspects of reproductive 17 
performance, including lifetime reproductive success and age at first birth, in either males or 18 
females. Our results do not support the prevailing assertion that exposure to infectious 19 
diseases in early life has long-lasting associations with later-life all-cause mortality risk or 20 
mortality putatively linked to chronic inflammation. Variation in adulthood conditions could 21 






SIGNIFICANCE STATEMENT 26 
 27 
Why has human life expectancy increased since 1850? A leading hypothesis proposes that 28 
limited exposure to childhood infections has reduced lifelong inflammation and enhanced 29 
survival, but tests of this hypothesis typically use all-cause mortality rates to estimate disease 30 
exposure. Meanwhile, links between early-life disease and reproduction have been neglected. 31 
We used data from pre-industrial Finnish populations to show that early-life disease exposure 32 
was not associated with all-cause mortality, mortality from cardiovascular disease, stroke and 33 
cancer, or reproductive success. Our study therefore does not support the prevailing 34 
contention that reduced exposure to early-life infections has increased life expectancy in 35 



















In industrialized nations, human life expectancy at birth has increased by around three 53 
months per year between 1840-2002 (1). While this is linked to improvements in child 54 
survival rates, there have been considerable increases in life expectancy of adults: in the UK 55 
in 1843, the mean expected age at death of a 20-year old was 60, while in 2011 it was 81 (2, 56 
3), a 50% increase in remaining lifespan. Longer adult life expectancy has been accompanied 57 
by increased incidence of previously rare chronic health problems and thus identifying the 58 
drivers of enhanced lifespan is an important question for global health. Declines in adult 59 
mortality rate since the 18th century in Europe were more closely linked to year of birth than 60 
to the year in which mortality was assessed, leading to the hypothesis that: “...the expectation 61 
of life was determined by the conditions which existed during the child’s earlier years” (4). 62 
The ‘cohort morbidity phenotype’ hypothesis suggests that the link between declining birth 63 
year mortality rate and increasing adult survival is due to reduced exposure to infectious 64 
diseases in early life and reduced lifelong burden of chronic inflammation (5–8). Thus, 65 
individuals experiencing exposure to infectious disease in early life are expected to have 66 
higher adulthood mortality risk. 67 
 68 
It is hypothesized that early-life exposure to infectious diseases could increase later-life 69 
mortality risk through a number of physiological mechanisms (6). Bacterial and viral 70 
infections elicit inflammatory immune responses, and chronic inflammation is associated 71 
with atherosclerosis, increased risk of stroke, cardiovascular disease (CVD) and mortality (9). 72 
Thus, early-life disease exposure is expected to be linked to adult mortality risk from these 73 
causes in particular (6). Support for this hypothesis comes from studies showing that 74 
exposure to high levels of early-life cohort mortality or infection is associated with middle-75 
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age mortality from CVD (10, 11); that exposure to infection is associated with chronically 76 
high levels of inflammation (12, 13); that high levels of inflammation are associated with 77 
CVD (14). This physiological mechanism is underpinned by the fact that natural selection 78 
should favour the expression of robust immune responses at young ages, even at the cost of 79 
lower later-life survival (15). 80 
 81 
Building on such knowledge, studies have tested the ‘cohort morbidity phenotype’ hypothesis 82 
by showing that early-life infections are associated with chronic inflammation and impaired 83 
later health (16, 17). A drawback is that these studies are performed on modern populations 84 
with good health care and therefore cannot estimate associations between early-life disease 85 
exposure and natural mortality risk. A second approach is to use historical data on natural-86 
mortality pre-industrial populations and to link early-life cohort mortality (a proxy for early-87 
life disease exposure) with later-life mortality (18–20). Studies of historical populations have 88 
however experienced at least one of several shortcomings. First, many studies are based on 89 
population-level statistics, meaning they cannot identify factors allowing some individuals to 90 
live long lives, despite being born in high-mortality cohorts. Second, most studies only 91 
consider all-cause cohort mortality rate as a measure of disease exposure, which may be 92 
driven by nutrition and social factors as well as disease. Third, it is often unknown which 93 
types of deaths are associated with early stressors, obfuscating the mechanism through which 94 
early-life disease exposure is associated with later mortality.  95 
 96 
The majority of studies of early-life disease exposure have focused solely on associations 97 
with later-life mortality, despite the fact that selection on life-history strategy should act 98 
through both survival and reproductive success. Life-history theory predicts that high 99 
mortality risk in early life should lead to earlier age at maturity (21), but associations between 100 
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early-life disease exposure and between-individual variation in reproductive success have 101 
been neglected.  A series of studies have shown that early life trauma, such as sibling 102 
mortality, parental separation, disadvantageous birth location and famine (22–25) are 103 
associated with earlier age at first reproduction and/or larger family size, suggesting adoption 104 
of a ‘fast’ life-history in high-stress, high-mortality environments. In contrast, childhood 105 
infections may have a non-lethal but damaging impact upon physiology which may impede 106 
reproduction during adulthood (26). These could include infections after birth leading to 107 
stunted growth in childhood and eventually reduced adult size (27), or even infections of 108 
focal individuals’ mothers leading to reduced birth weight, which may lead to reduced birth 109 
weight of focal individuals’ offspring (28, 29). Nevertheless, it has been shown that the 110 
direction of the association between final adult height and fertility is variable across 111 
populations  (30).   112 
 113 
We used church register data collected from seven Finnish populations across the 18th and 114 
19th centuries to determine the association between early-life exposure to infectious diseases 115 
and (1) later-life mortality risk; (2) cause of death; (3) reproductive success. These 116 
populations had no access to modern contraception or healthcare (31) and as a result ~40% of 117 
children died of disease before age 15. Having survived to age 15, mean lifespan in our 118 
sample was ~56 years and individuals produced an average of ~4 surviving offspring, with 119 
>99% of individuals born to parents aged <50. We used cause-of-death data recorded by 120 
churches to adopt a measure of disease exposure based on the local probability of child death 121 
from infectious diseases during the early years of an individual’s life. Crucially, we 122 
controlled for other salient variables reflecting early-life conditions and known to influence 123 
fitness in these populations (SI Appendix, Table S1 and Fig. S1), including social class at 124 






There was considerable between-year variation in the prevalence of deaths from infectious 129 
diseases in the early years of our study individuals’ lives. We used these data to calculate a 130 
measure of early-life exposure to infectious diseases for each of the first five years of life of 131 
each individual, based on the proportion of children dying from infectious diseases in their 132 
parish in each year. We recorded the number of children aged 0-10 alive in each parish in 133 
each year, 1751-1855 (a total of 195,170 person-years). In 194,182 (>99.5% of) cases, the 134 
child had a known cause of death or survived, while in the remaining 988 cases, the child 135 
died of an unknown cause; these 988 cases were not included in our calculations of early-life 136 
disease exposure (SI Appendix, Table S2). During these years, 4780 child deaths of known 137 
cause were recorded, with 73% due to infectious diseases (SI Appendix, Table S3). We 138 
calculated annual parish-specific variation in child mortality rate from infectious diseases by 139 
dividing the number of child (aged 0-10) deaths in each parish due to infections in each year, 140 
1751-1855, by the number of children alive in each parish in the same year. The child 141 
mortality rate from infectious diseases varied substantially across the study period in all 142 
seven parishes (Fig. 1). We de-trended the child mortality rate from infectious diseases by 143 
applying a Hodrick-Prescott filter to data from each parish using the R package ‘mFilter’, 144 
with a filtering term of 100. This decomposed variation in child mortality rate from infectious 145 
diseases in each parish into a long-term smoothed ‘trend’ component (Fig. 1) and the short-146 
term deviation from the trend, or the ‘cycle’ (Fig. 2). The ‘cycle’ component for each year 147 
was multiplied by 100 to aid model convergence, and we refer to this measure herein as 148 
annual ‘disease exposure’ (Fig. 2). Each individual was therefore defined by their potential 149 
early exposure to infections, rather than simply the level of all-cause cohort mortality (8, 18, 150 
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19), on a continuous quantitative scale, accounting for temporal changes in conditions, and 151 
specific to the parish in which they were born. We designed analyses in order to determine 152 
whether our measure of disease exposure in each of the first five years of life was associated 153 
with later-life survival and reproductive success.  154 
 155 
Mortality risk   156 
 157 
Our mixed-effects Cox model analyses showed that greater disease exposure in each of the 158 
first five years of life was not associated with increased mortality risk in adulthood (N=7283). 159 
Controlling for a higher mortality risk among poor individuals and males, and variation 160 
between parishes, as well as other fixed and random effects (Table 1), disease exposure 161 
measured in each of the first five years of life was not significantly associated with hazard of 162 
mortality after age 15 and nor was the association between early-life disease exposure and 163 
mortality risk dependent upon parish, social class, or sex (SI Appendix, Table S4). When we 164 
restricted our analyses to individuals who survived to at least the age of 50 (N=3822) and 165 
who were therefore most likely to experience stroke, CVD and cancer, we again found no 166 
evidence for an association between early-life disease exposure and mortality risk and no 167 
indication of interactions with individual parish, social class or sex (SI Appendix, Table S4).  168 
 169 
Cause of death 170 
 171 
Mixed-effects Cox models showed that there was no significant association between early-172 
life disease exposure and cause of death. We tested for an association between disease 173 
exposure in each of the first five years of life and death from CVD, stroke and cancer, on 174 
which the ‘cohort morbidity phenotype’ focuses (8). Individuals were scored as 1 (a ‘failure’) 175 
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if they died of CVD, stroke or cancer, and 0 if they died of other causes or were censored 176 
without dying (SI Appendix, Table S5 & Fig. S2). As above, we first performed the analysis 177 
on all individuals who survived to at least the age of 15. There was no statistical support for 178 
an association between early-life disease exposure in any of the first five years of life and 179 
death from CVD, stroke or cancer (SI Appendix, Table S6). Although there was some 180 
evidence to support an interaction between early disease exposure and social class (Disease 181 
Year 4:Social class (Poor) Hazard = 0.79; 95% C.I.=0.62-1.00; χ²1=4.17; P=0.0.041) 182 
suggesting that Poor individuals with higher early-life disease exposure in the fourth year of 183 
life were less likely to later die of infection (Table S7), this interaction was only weakly 184 
statistically supported over the base model with ΔAIC=-2.02 (36). Nevertheless, it suggested 185 
a trend for a mildly protective effect of early disease exposure and later death risk from CVD, 186 
stroke or cancer in Poor individuals. We also repeated this analysis on individuals who 187 
survived to at least age 50, since the majority (263/346) of individuals affected by these death 188 
causes were aged over 50. Once again, there was no evidence that early-life disease exposure 189 
was associated with cause of death, nor any evidence for interactions between disease 190 
exposure and parish, social class or sex (SI Appendix, Table S6).   191 
 192 
Lifetime reproductive success 193 
 194 
We next assessed links between early-life disease exposure and later-life reproductive 195 
success in individuals who married and survived to at least age 50 and who had therefore 196 
completed their reproductive lifespans with the opportunity to reproduce. We analysed data 197 
from females and males separately, due to their differing social and physiological factors 198 
affecting reproductive schedules. First, we used linear mixed-effects models to show that 199 
there was no association between early-life disease exposure and Box-Cox transformed 200 
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lifetime reproductive success (LRS) in females (N=1512), defined as the number of offspring 201 
an individual produced which survived to age 15 (best-fitting single year, Disease year 1 202 
estimate = -0.0202±0.0112; χ²(1)=3.25; P=0.071; SI Appendix, Table S8). This model 203 
controlled for variation between parishes (χ²(6)=68.60; P<0.001), lower LRS in Poor 204 
compared to Rich individuals (estimate=-0.24±0.04; χ²1=44.77; P<0.001) and non-significant 205 
effects of birth interval, birth season and twinning status. There was also no statistical support 206 
for interactions between early disease exposure and social class or parish (SI Appendix, Table 207 
S8). In males (N=1333), there was once again no support for an association between early-208 
life disease exposure and LRS (best-fitting single year, Disease year 4 209 
estimate=0.0068±0.0118; χ²1=0.33; P=0.563), nor any support for interactions with social 210 
class or parish (SI Appendix, Table S8).  211 
 212 
We next determined whether there were any links between early-life disease exposure and 213 
other components of reproduction which constitute LRS, namely age at first reproduction, the 214 
number of children born, or child survival rate. In neither sex, however, did we find any 215 
support for associations between early-life disease exposure and any of these measures of 216 
reproductive success, either as a main effect or in interactions with social class or parish (SI 217 




It has been hypothesized that recent increases in human lifespan have been brought about by 222 
reduced exposure to infectious diseases in early life and reduction of lifelong inflammation 223 
and associated chronic diseases such as CVD, stroke and cancer (5–8). Tests of this 224 
hypothesis have used data from historical populations to support a link between cohort all-225 
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cause mortality rate and later-life survival, but have not assessed later-life survival in relation 226 
to measures of early-life disease exposure based on disease prevalence, or determined how 227 
early disease exposure is linked to mortality risk specifically from CVD, stroke and cancer. 228 
Studies of how early-life disease exposure may impact upon later-life reproductive success 229 
are also extremely rare. We used data from seven pre-industrial Finnish populations and 230 
addressed these shortcomings by (1) quantifying variation in early-life disease exposure as 231 
the proportion of children alive in each of the first five years of an individual’s life who died 232 
of infectious diseases; (2) assessing links between disease exposure and cause of death; (3) 233 
determining the association between early-life disease exposure and reproduction. Our results 234 
show that individuals experiencing higher early-life disease exposure do not experience 235 
higher all-cause mortality risk or risk of mortality from CVD, stroke or cancer during 236 
adulthood. We also found no support for associations between early-life disease exposure and 237 
reproductive performance in either males or females. Our results do not support the link 238 
between early-life disease exposure and chronic inflammation-associated mortality risk 239 
which forms the crux of the ‘cohort morbidity phenotype’ hypothesis.    240 
 241 
Our analyses showed that, controlling for individual parish, social class, sex, birth season, 242 
twinning status, birth interval and temporal changes in disease exposure (Fig. 1) there was no 243 
statistical support for an association between early-life disease exposure and mortality risk 244 
after age 15 (Table 1 and SI Appendix, Table S4). Previous studies have found evidence for 245 
links between early-life cohort mortality rate and later survival (4, 5, 8), but without 246 
considering that such a measure of disease exposure could be confounded by spatial 247 
variation, social status, other intrinsic and extrinsic conditions as well as disease exposure, 248 
and improvements in living conditions and hygiene across time. Demographic studies have 249 
applied statistical techniques such as Hodrick-Prescott decomposition to trending 250 
12 
 
environmental data and found generally weak associations between early- and later cohort 251 
mortality (37–40), though some of these studies have still detected significant correlations 252 
(19, 41). By applying Hodrick-Prescott decomposition we were able to account for declines 253 
in death rates from infection across time by using deviations from this trend as our measure 254 
of early-life disease exposure (Fig. 2). Unlike these studies, however, we use a measure of 255 
disease exposure explicitly based on prevalence of deaths from the infectious diseases most 256 
likely to affect infants (SI Appendix, Tables S2 & S3).  257 
 258 
Early-life disease exposure may influence later-life health in a number of ways, and it is this 259 
complexity that may have prevented us from detecting significant associations. For example, 260 
early infections may have negative associations with later health through chronic 261 
physiological ‘scarring’, but may also have positive associations due to acquired immunity or 262 
selection of the most robust individuals who were able to survive the harsh early environment 263 
(42). There may also be changes in the factors which influence mortality in different parts of 264 
the life course, such that the relative importance of scarring and selection may vary with age 265 
(43) and the effects of early adversity may be short-lived, or be negligible in comparison to 266 
events which occur in adult life (39). A study using data from Sweden, collected 1813-1968 267 
and calculating early-life disease risk based on neonatal mortality rates, showed that effects 268 
of exposure on mortality varied with age: individuals experiencing higher neonatal mortality 269 
rates showed higher mortality initially, but lower mortality in later life (44). These results 270 
suggest initial scarring effects of disease at younger ages, followed by a strengthening 271 
influence of acquired immunity and/or selection of robust individuals at later ages. Thus, 272 
rather than being unimportant for later-life survival, early-life infections may have both 273 
negative (through scarring) and positive (through acquired immunity and/or selection) 274 
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associations with later survival which may combine to culminate in no detectable overall 275 
effect.         276 
 277 
The ‘cohort morbidity phenotype’ (5–8) proposes a link between infection, chronic 278 
inflammation, and risk of CVD, stroke and cancer (14). The exact prevalence of these 279 
diseases in our study population is unknown: although 9.6% of deaths were due to CVD or 280 
stroke, a further 13.7% of deaths were due to ‘old age’ and could have been related to chronic 281 
inflammation (SI Appendix, Table S5). Exposure to infection in early life has also been 282 
linked to respiratory disorders in later life (16, 17, 45), which is noteworthy given that 14.9% 283 
of deaths in our studied individuals were from tuberculosis (SI Appendix, Table S5). 284 
Focusing on deaths from CVD, stroke and cancer, we did not find evidence that early-life 285 
disease exposure was associated with these causes of death, linked to chronic inflammation 286 
by the ‘cohort morbidity phenotype’ (SI Appendix, Table S6). It should be noted that, with 287 
only 346/7283 (5% of) individuals scored as dying of CVD, stroke or cancer, our statistical 288 
power to detect links between early disease exposure and cause of death may have been low. 289 
Meanwhile, studies of contemporary populations experiencing high exposure to infection and 290 
high levels of inflammatory markers rarely show signs of CVD despite their short lifespans, 291 
suggesting that a low level of CVD, stroke and cancer is simply the ancestral state and that 292 
high prevalence of these conditions may be a consequence of longer lifespans in 293 
industrialized populations (46). Finally, it may be possible that adverse effects of chronic 294 
inflammation are only apparent in populations experiencing resource-rich or pathogen-poor 295 
environments, and that in our (relatively) resource-poor and pathogen-rich environments, 296 
heightened inflammatory responses are advantageous or neutral. Our study individuals were 297 
born before 1850, and thus it is possible that our results may not be generalizable to later 298 
cohorts, which experienced increased adult nutrition and healthcare. On the other hand, if 299 
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chronic inflammation does not lead to CVD, stroke and cancer in low-nutrition, high-300 
pathogen environments, then the ‘cohort morbidity phenotype’ would not offer an 301 
explanation for longer modern lifespans being due to reduced or delayed instances of these 302 
disorders. 303 
 304 
The majority of studies of early-life disease exposure have focused solely on associations 305 
with mortality, and our results are among the first to address links between early-life disease 306 
exposure and reproductive success. We found, however, that associations between early-life 307 
disease exposure and lifetime reproductive success (LRS), age at first reproduction, lifetime 308 
breeding success and child survival rate were absent in both sexes. Life-history theory 309 
predicts that high mortality risk in early life should lead to earlier age at maturity (21), which 310 
should be associated with higher LRS, predictions which have been supported by population- 311 
(23, 47) and individual-level studies showing that adverse early-life conditions such as 312 
experience of mortality, a deprived upbringing, experience of famine or chronic childhood 313 
illness are associated with earlier age at first birth and higher fertility (22, 23, 25). In contrast, 314 
early-life stressors such as low food availability have been linked to later-life health problems 315 
(48) and, in our study population, reduced reproductive success (49, 50). These effects may 316 
be mediated through neonatal infections which stunt growth and diminish later reproductive 317 
success (26, 27), or maternal infections which reduce the birthweight of focal individuals (28, 318 
29). In a historical German population, birth during a high-mortality period was associated 319 
with lower child survivorship in males and lower lifetime births in females (51). Thus, 320 
adverse conditions in early pre- or post-natal life may slow growth and development, affect 321 
reproductive physiology and postpone first birth (52). As with survival, the conflicting 322 
negative (scarring) and positive (selection) effects of disease exposure may underpin our 323 
finding of no overall association between early-life disease exposure and later-life 324 
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reproductive success. Alternatively, the lack of association in the present study could indicate 325 
that links detected in previous studies were due to factors other than disease. A recent study 326 
on data from 251 20th century English women used path analysis to show that although social 327 
class was linked to age at first birth, and illness in the first year of life was linked to adult 328 
height, there was no direct or indirect effect of childhood illness on age at first birth or LRS 329 
(53). Our results, with N>1000 are therefore unlikely to reflect lack of statistical power and it 330 
may therefore simply be that effects of early-life infections on reproduction are weak and 331 
overshadowed by socio-economic factors.  332 
 333 
Unlike many previous studies testing for links between early-life disease exposure and later-334 
life fitness, we (1) incorporated data on disease prevalence into our measure of early-life 335 
disease exposure; (2) determined associations between disease exposure and cause of death; 336 
(3) assessed associations between disease exposure and reproductive success; (4) controlled 337 
for several important social factors; (5) de-trended our measure of early-life disease exposure 338 
to account for temporal trends; (6) examined early-life effects not only around birth but up to 339 
age five. An ‘ideal’ study would link full health records from each individual documenting 340 
previous illness with lifetime follow-up on survival and reproduction. Our results should be 341 
interpreted with the acknowledgment that infection of any individual in our population at any 342 
time is unknown. Instead, our measure of disease exposure assumes that a higher child 343 
mortality rate from infection meant that, on average, individuals experiencing such conditions 344 
were more likely to be exposed to infections. In addition, we included the 22% of child 345 
deaths due to ‘unknown diseases’ in the ‘infectious’ category since deaths from infection 346 
were generally more common than those due to other causes, especially in children (Tables 347 
S3 & S5), but this may have introduced noise into our calculation of disease exposure if not 348 
all such unknown diseases were indeed infectious. It therefore remains possible that inability 349 
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to detect an association between early disease exposure and fitness is due to our way of 350 
calculating early disease exposure. Ability to accurately determine cause of death with poor 351 
medical knowledge is a general caveat of using historical data. These two caveats aside, a 352 
strength is that we have used parish-specific records rather than nationwide figures, thereby 353 
gaining the most geographically-restricted estimate of disease exposure possible.  354 
 355 
The results of our study strongly challenge the hypothesis that links between early and later-356 
life mortality rates are mediated through effects of early-life infectious diseases on chronic 357 
inflammation. Longitudinal study of contemporary populations will be essential for detecting 358 
the mechanisms underpinning such effects (53); for example, for disentangling the role of 359 
early and later conditions in influencing mortality risk. With the increasing availability of 360 
national, individual-based health data, this endeavour will be achievable in a more explicit 361 
manner than shown here. Our study, however, uses data from 100 cohorts of a pre-industrial 362 
population and  controls for variation in social class and birth circumstances to provide a 363 
unique snapshot of how early-life conditions may have influenced human populations for 364 
much of our evolutionary history (6, 7). We conclude, in agreement with several other 365 
authors (37, 39, 40) that the influence of improved adult, rather than childhood, conditions 366 
are likely to have driven recent improvements in life expectancy. 367 
 368 
MATERIALS AND METHODS 369 
 370 
Study population and data collection 371 
 372 
We investigated associations between early-life disease exposure and later-life survival and 373 
reproductive success using longitudinal data collected from 18th-19th century church records 374 
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in seven populations, termed ‘parishes’, located across the southern half of Finland. Prior to 375 
the 1870s, these populations had high birth and death rates, primitive agricultural technology, 376 
unreliable contraception and medical care (31) and were strictly monogamous. Individuals 377 
were divided into two social classes: “Rich” individuals included farm owners, merchants 378 
and craftsmen; “Poor” individuals included crofters and labourers (32).  379 
 380 
Causes of death and early-life disease exposure 381 
 382 
We have collected data including birth, parentage, marriage, reproduction and death for a 383 
total of 72,564 individuals in the parishes of Hiittinen, Ikaalinen, Jaakkima, Kustavi, 384 
Pulkkila, Rautu and Rymättylä born 1702-2012. We restricted our analyses to 21,539 385 
individuals born after 1750, since before this records were patchy, and born before 1851, 386 
ensuring that we only used data from individuals with natural mortality and fertility (31). We 387 
further restricted our analyses to individuals who survived to at least age 15 (15,237) and 388 
those of known maternal identity and social class (N = 7327). This was done to ensure we 389 
captured longer-term effects of disease exposure; and to control for variation in survival and 390 
reproductive success between families and social classes (32). Finally, because birth order 391 
(34), twinning status (33) and birth season (35) are all linked to fitness in this population, we 392 
restricted our analyses to individuals for whom this information was recorded, leaving a final 393 
sample size of 7283 individuals, born 1751-1850. None of our study individuals moved 394 
between parishes between birth and adulthood. 395 
 396 
Based on previous studies examining links between early exposure to mortality and later-life 397 
health and fitness (19, 38–40), we aimed to estimate an individual’s experience of infectious 398 
diseases in their first five years of life, as illustrated by the prevalence of death from 399 
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infectious diseases recorded by the church (54). Since children and adults are vulnerable to 400 
different diseases in this population (SI Appendix, Tables S3 & S5), we recorded the number 401 
of individuals aged 0-10 years who were alive in the parish in each year, 1751-1855, a total 402 
of 194,182 person-years (SI Appendix, Table S2), during which time 4780 children died of a 403 
known cause, 73% of which were due to infectious diseases (SI Appendix, Table S3).  22% 404 
of deaths were from an ‘unknown disease’, which we included in the ‘infectious’ category. 405 
We gained a parish-specific measure of ‘disease exposure’ for each year by dividing the 406 
number of children dying of infectious diseases in a given year in a given parish by the 407 
number of children alive in the same parish in the same year (Fig. 1). Thus, our measure of 408 
early-life disease exposure is based on the child mortality rate from infectious diseases during 409 
an individual’s early life. We then de-trended this measure using Hodrick-Prescott 410 
decomposition, and used the deviations from the trend (the ‘cycle’ component) as our 411 
measure of disease exposure (Fig. 2). Early-life disease exposure was multiplied by 100 prior 412 
to use in analysis to aid model convergence. 413 
 414 
Statistical analysis 415 
 416 
We determined the association between disease exposure in each of the first five years of life 417 
and later-life fitness, controlling for other potentially confounding effects (SI Appendix, 418 
Table S1). All models described below were mixed-effects models with maternal identity and 419 
birth year as random effects, to account for between-family and -cohort variation in fitness. 420 
All models estimated the association between early-life disease exposure and fitness after 421 
controlling for the following fixed effects, which were retained in all models. Parish (seven 422 
levels), social class (Rich or Poor) and sex (Male or Female) were all included as categorical 423 
fixed effects. Since child survival is higher for those born in August, September and October 424 
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compared to other months (35), birth season was included as a two-level categorical variable 425 
(High or Low survival). First-born males have higher prospects of wealth inheritance, 426 
marriage and reproduction in this population, and individuals born with a longer intervening 427 
period after their previous sibling may have higher fitness (34). We incorporated both of 428 
these effects into a four-level categorical variable, Inter-Birth Interval (IBI: Firstborn; born 429 
<2 years after sibling; born <3 years after sibling; born >3 years after sibling). Finally, all 430 
models accounted for the link between twin status at birth and later-life fitness (33) by 431 
including twin status at birth (singleton or twin) as a categorical fixed effect. All analyses 432 
were conducted in R version 3.2.3. 433 
 434 
Mortality risk 435 
 436 
We determined the association between early-life disease exposure and mortality risk after 437 
the age of 15 in 7283 individuals using mixed-effects Cox models in the R package ‘coxme’. 438 
We constructed a ‘base’ model containing the fixed and random effects described above 439 
(model 0) and then built a series of models testing the association between early-life disease 440 
exposure and mortality risk. We considered disease exposure in each of the first five years of 441 
an individual’s life as separate variables: Year 0 (birth year), Year 1, Year 2, Year 3 and Year 442 
4. We first tested for main effects of disease exposure in each of the first five years of life 443 
separately by (models 1-5) comparing the ‘base’ model with separate models containing each 444 
of the first five years’ disease exposure, fitted as covariates, using likelihood ratio test 445 
(LRTs), where the χ²-distributed test statistic is calculated as -2*(LogLikmodel1 – 446 
LogLikmodel2). We next (model 6) fitted all five disease exposure years as covariates in the 447 
same model and compared model 6 to model 0 using an LRT. We determined which of 448 
models 1-5 fitted best by comparing their Akaike Information Criterion (AIC) values, where 449 
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the lowest value provided the best fit (36). We did not encounter any situation where more 450 
than one of models 1-5 outperformed model 0. This allowed us to determine which disease 451 
exposure year was most strongly associated with mortality risk. We took the best-fitting 452 
disease exposure year forwards into model 7, which tested for a non-linear association 453 
between the best-fitting disease exposure year and survival by comparing the model with a 454 
linear term of disease exposure to one with both linear and quadratic terms. Finally, we tested 455 
for interactions involving the best-fitting disease exposure year by comparing the model with 456 
the main effect of the best-fitting disease exposure year to models with interactions between 457 
disease exposure and parish (model 8), social class (model 9) and sex (model 10). We 458 
subsequently restricted the analyses to individuals who lived to at least age 50 (N=3822), 459 
since these individuals are most likely to fall victim to CVD, stroke and cancer.  460 
 461 
Cause of death 462 
 463 
We next aimed to determine whether early-life disease exposure was associated with 464 
increased risk of death from stroke, CVD or cancer versus other causes. Each individual was 465 
scored as dying from stroke, CVD or cancer (1; 346 individuals) with the remainder (6937 466 
individuals) scored as 0. Cause-of-death analyses were performed using mixed-effects Cox 467 
models, following the same fixed and random effects structure and model selection procedure 468 
as described above. We then repeated this analysis on individuals who survived until at least 469 
the age of 50, since 263/346 (76%) of deaths from these causes occurred in individuals aged 470 
50 and over.  471 
 472 




We next determined the association between early-life disease exposure and later-life 475 
reproductive success by quantifying lifetime reproductive success (LRS) as the number of 476 
children an individual produced that survived to age 15. From the original sample size of 477 
7283, we removed data from 1200 individuals who were unmarried or whose marriage status 478 
was unknown; 488 individuals who had unknown LRS; 1417 individuals whose reproductive 479 
success was unknown or whose children had unknown fates to age 15; 1333 individuals who 480 
failed to survive to the age of 50 and therefore complete their reproductive lifespan (49). We 481 
therefore focused on fertility differences within marriage to determine differences in 482 
reproductive capacity, rather than ‘mating success’ (or marriage) which in influenced by a 483 
host of social and cultural factors which contribute to finding a partner. The final data set for 484 
analysis of LRS contained 2845 individuals, with 1512 females and 1333 males. The analyses 485 
were separated by sex due to the biological and social differences governing variation in 486 
reproductive success between the sexes in this population. We visually inspected diagnostic 487 
plots of several different modelling structures, including linear mixed-effects models 488 
(LMMs) of untransformed LRS; LMMs of log-transformed LRS; LMMs of Box-Cox 489 
transformed LRS; generalized linear mixed effects models of untransformed LRS with 490 
Poisson, Poisson-lognormal and negative binomial error structures. In both males and 491 
females, Box-Cox transformation provided the most favourable diagnostics, so LRS was 492 
modelled using linear mixed-effects models (LMMs) of (LRS+1)0.5 in the R package ‘lme4’. 493 
The fixed and random effect structures of models 1-9 were the same as for the Cox models 494 
described above, although since we performed separate analysis for males and females, we 495 
did not fit model 10, which included the interaction between early-life disease exposure and 496 




Finally, we tested for associations between early-life disease exposure and the reproductive 499 
traits which contribute to LRS. We therefore performed analyses determining whether early-500 
life disease exposure was associated with later age at first reproduction, reduced lifetime 501 
breeding success (number of children born) and/or child survival rate to age 15. These 502 
analyses are described in full in the SI Appendix.  503 
 504 
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FIGURE LEGENDS 681 
 682 
Figure 1: Changes in child mortality from infectious disease in each year, 1751-1855 and 683 
calculation of our measure of early-life disease exposure. Child (aged 0-10) mortality rate 684 
from infectious disease varied substantially across the early lives of our study individuals. 685 
Grey points and lines show the proportion of children alive in a given year that died of an 686 
infectious disease; black line shows the ‘trend’ component of Hodrick-Prescott 687 
decomposition of the time series. Data and trends were calculated and are shown separately 688 
for (A) all parishes combined; (B) Hiittinen; (C) Ikaalinen; (D) Jaakkima; (E) Kustavi; (F) 689 
Pulkkila; (G) Rautu; (H) Rymattyla. 690 
 691 
Figure 2: The deviations from the trend in child mortality from infectious disease in the early 692 
years of our study individuals’ lives, represented as the ‘cycle’ component of the Hodrick-693 
Prescott decomposition. The parish-specific deviations from the trend, our measure of early-694 
life disease exposure, varied substantially across cohorts in (A) all parishes combined; (B) 695 
Hiittinen; (C) Ikaalinen; (D) Jaakkima; (E) Kustavi; (F) Pulkkila; (G) Rautu; (H) Rymattyla.  696 
 697 
 698 
